Temple treats 1st patient in US in trial of gimsilumab for patients with COVID-19 and ARDS

Temple University Hospital has treated the first patient in the United States in the BREATHE clinical trial evaluating the impact of intravenous treatment with gimsilumab on mortality for patients with COVID-19 and acute respiratory distress syndrome (ARDS).